NCT02099682

Long-term Use of Takepron Capsules on the Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Low-dose Aspirin

Takepron Capsules 15/ Orally Dispersing (OD) Tablets 15 Special Drug Use Surveillance Long-term Use Survey on the Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Low-dose Aspirin

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 3,366 (actual)
• Sponsor: Takeda · Industry
• Sex: All
• Age: —
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to investigate the safety and efficacy of long-term administration of lansoprazole (Takepron) for up to 12 months in the routine clinical setting in patients receiving low-dose aspirin

Detailed description

This is a special survey on long-term use (for up to 12 months) of lansoprazole (Takepron) to determine the incidence of adverse drug reactions in the routine clinical setting in patients receiving low-dose aspirin. The usual adult dosage is 15 mg of lansoprazole administered orally once daily.

Conditions

• Gastric or Duodenal Ulcers

Interventions

Type	Name	Description
DRUG	Lansoprazole	Lansoprazole Capsules 15/ OD Tablets

Timeline

• Start date: 2010-08-01
• Primary completion: 2014-01-01
• Completion: 2014-01-01
• First posted: 2014-03-31
• Last updated: 2016-11-04
• Results posted: 2015-06-25